Stefano Messina, MD

Original Contribution

Contrast Minimization With the New-Generation DyeVert Plus System for Contrast Reduction and Real-Time Monitoring During Coronary and Peripheral Procedures: First Experience

07/25/2017

Arturo Giordano , MD, PhD;

Nicola Corcione , MD;

Paolo Ferraro , MD;

Stefano Messina , MD;

Gennaro Maresca , MD;

Raffaella Avellino , BSc;

Giovanni Napolitano , MD;

Elena Cavarretta , MD, PhD;

Contrast-induced nephropathy remains the main adverse effect of contrast administration. We appraised the DyeVert Plus system inclusive of contrast reduction and real-time monitoring in a consecutive series of coronary or peripheral...

Contrast-induced nephropathy...

07/25/2017

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Stefano Messina, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products